249 related articles for article (PubMed ID: 17154522)
1. Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Kunkel MW
J Med Chem; 2006 Nov; 49(23):6922-4. PubMed ID: 17154522
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Welsh W; Arora S; Farruggia G; Masotti L
J Med Chem; 2005 Aug; 48(17):5604-7. PubMed ID: 16107161
[TBL] [Abstract][Full Text] [Related]
3. Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L
J Med Chem; 2007 Jul; 50(14):3167-72. PubMed ID: 17559205
[TBL] [Abstract][Full Text] [Related]
4. Substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Farruggia G; Masotti L
Bioorg Med Chem; 2004 Mar; 12(5):1121-8. PubMed ID: 14980624
[TBL] [Abstract][Full Text] [Related]
5. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V
J Med Chem; 2002 Jun; 45(12):2666-9. PubMed ID: 12036377
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activities of substituted 3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones and studies on their mechanisms of action.
Andreani A; Granaiola M; Locatelli A; Morigi R; Rambaldi M; Varoli L; Vieceli Dalla Sega F; Prata C; Nguyen TL; Bai R; Hamel E
Eur J Med Chem; 2013 Jun; 64():603-12. PubMed ID: 23685944
[TBL] [Abstract][Full Text] [Related]
8. Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells.
Leoni A; Locatelli A; Morigi R; Rambaldi M; Cappadone C; Farruggia G; Iotti S; Merolle L; Zini M; Stefanelli C
Eur J Med Chem; 2014 May; 79():382-90. PubMed ID: 24747749
[TBL] [Abstract][Full Text] [Related]
9. 3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
Ferandin Y; Bettayeb K; Kritsanida M; Lozach O; Polychronopoulos P; Magiatis P; Skaltsounis AL; Meijer L
J Med Chem; 2006 Jul; 49(15):4638-49. PubMed ID: 16854069
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
11. Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation.
Natarajan A; Guo Y; Harbinski F; Fan YH; Chen H; Luus L; Diercks J; Aktas H; Chorev M; Halperin JA
J Med Chem; 2004 Oct; 47(21):4979-82. PubMed ID: 15456240
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones.
Christensen MK; Erichsen KD; Trojel-Hansen C; Tjørnelund J; Nielsen SJ; Frydenvang K; Johansen TN; Nielsen B; Sehested M; Jensen PB; Ikaunieks M; Zaichenko A; Loza E; Kalvinsh I; Björkling F
J Med Chem; 2010 Oct; 53(19):7140-5. PubMed ID: 20845961
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads.
Singh P; Kaur M; Verma P
Bioorg Med Chem Lett; 2009 Jun; 19(11):3054-8. PubMed ID: 19398334
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells.
Saito H; Tabata K; Hanada S; Kanda Y; Suzuki T; Miyairi S
Bioorg Med Chem Lett; 2011 Sep; 21(18):5370-3. PubMed ID: 21802947
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Voltattorni M; Zini M; Stefanelli C; Masotti L; Shoemaker RH
J Med Chem; 2008 Dec; 51(23):7508-13. PubMed ID: 19006285
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of 6H-isoindolo[2,1-a]indol-6-ones, analogues of batracylin, and related compounds.
Guillaumel J; Léonce S; Pierré A; Renard P; Pfeiffer B; Arimondo PB; Monneret C
Eur J Med Chem; 2006 Mar; 41(3):379-86. PubMed ID: 16442188
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and COMPARE analysis of bis-indole derivatives.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Landi L; Prata C; Dalla Sega FV; Caliceti C; Shoemaker RH
Bioorg Med Chem; 2010 May; 18(9):3004-11. PubMed ID: 20395150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
